TEST:

geneType Breast Cancer Risk Assessment Test

"Genetic Technologies Limited...is pleased to announce the company is establishing a clinical implementation study with breast imaging centres across New York, Miami and Houston."

P=NA | N=NA| "Genetic Technologies Limited...is pleased to announce the publication of another research paper supporting the utilisation of geneType Breast Cancer Risk Assessment Test in the peer-reviewed journal Cancer Prevention Research....GeneType improved discrimination and risk categorization when compared to one of the most well-known models, the Breast Cancer Risk Assessment Tool (BCRAT). Over a five-year period, at-risk women classified ≥3% 5-year risk by geneType had a 1.829 times increased incidence of breast cancer compared to the general population, which was higher than the 1.413 times increased incidence for women classified ≥3% by BCRAT."